Gravol Tablet contains Dimenhydrinate 50mg, an antihistamine with antiemetic and antivertigo properties, primarily indicated for the prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness. Dimenhydrinate acts by blocking histamine H1 receptors in the central nervous system, thereby reducing vestibular stimulation and suppressing the vomiting center in the medulla. This medication is effective in managing symptoms related to motion sickness, including nausea, vomiting, and vertigo, and may also be used adjunctively in other conditions causing nausea. Gravol Tablet should be administered orally, with dosage adjusted according to patient age and clinical response. Common side effects include drowsiness, dry mouth, blurred vision, and dizziness; therefore, caution is advised when operating machinery or driving. Contraindications include hypersensitivity to dimenhydrinate or related compounds, narrow-angle glaucoma, and certain respiratory conditions such as asthma. Use during pregnancy and lactation should be under medical supervision. Patients with pre-existing medical conditions or those taking other central nervous system depressants should consult a healthcare professional prior to use. Gravol Tablet offers a reliable therapeutic option for the symptomatic relief of motion sickness-related discomfort, enhancing patient comfort during travel.